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The problem of postoperative atrial fibrillation (AF) has receivedconsiderable attention over the years. Nonetheless, this is probablystill the most common complication in adult patients undergoingcardiac surgery and one of the most common complications in adultpatients undergoing noncardiac thoracic surgery.
Perhaps because of effective antiarrhythmic medications that can be used to treat
patients with postoperative AF, these arrhythmias were often thought to be benign,
producing only transient discomfort, palpitations, or shortness of breath. For pa-
tients undergoing cardiac surgery, we now have substantial evidence that postop-
erative AF is associated with increases in the use of hospital resources, length of
hospital stay, and hospital costs. Moreover, postoperative AF has been associated
with a variety of other adverse outcomes, including perioperative myocardial
infarction, congestive heart failure (CHF), ventricular arrhythmias, renal insuffi-
ciency, infection, pneumonia, increased need for inotropic medications, increased
use of the intra-aortic balloon pump, prolonged ventilation, increased frequency of
reintubation for respiratory distress, increased need for readmission to the intensive
care unit, and increased need for tracheostomy. There is a growing recognition that
one of the most important clinical consequences of postoperative AF might be an
increased incidence of perioperative stroke. We have also come to recognize that
these arrhythmias might be persistent or recurrent, even long after discharge from
the hospital.
Clinical investigation in adults undergoing cardiac surgery has focused mainly on
2 fronts: (1) the identification of risk factors for the development of postoperative
AF and (2) various strategies for prophylaxis. The most commonly identified risk
factors in retrospective studies are a previous history of atrial arrhythmias and
increasing patient age. Other risk factors that have been reported include valvular
heart disease, male sex, chronic obstructive pulmonary disease, the presence of right
coronary artery stenosis, left ventricular hypertrophy, CHF, and various electrolyte
abnormalities.
Many investigators have suggested that patients who could be identified at high
risk for this complication prospectively might benefit from prophylaxis strategies. It
is important to remember that because postoperative AF occurs in only the minority
of patients, many patients must be treated to prevent this complication in just the
minority. As a result, prophylaxis strategies should come at low risk and (relatively)
low cost. Prospective randomized trials have examined the utility of a variety
pharmacologic agents used prophylactically, including -blockers, sotalol, amioda-
rone, verapamil, diltiazem, magnesium, digoxin, dexamethasone, glucose-insulin-
potassium infusions, tri-iodothyronine, procainamide, alinidine, and quinidine. The
results have often been conflicting, and as a result, there is no consensus. Most
authorities would agree that the use of -blockers postoperatively can serve as
effective prophylaxis. The evidence also suggests that amiodarone or sotalol, when
used appropriately, can reduce the incidence of postoperative AF in adults under-
going cardiac surgery. Evidence from prospective randomized trials also suggests
that the use of mild (rather than moderate) hyothermia, posterior pericardiotomy,
atrial pacing, and heparin-coated cardiopulmonary bypass circuits might help to
reduce the incidence of postoperative AF.
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The issue of postoperative AF after noncardiac surgery
has received much less attention. Except for patients under-
going major thoracic, vascular, and abdominal procedures,
the incidence of postoperative AF is probably very low. The
study of adult patients undergoing noncardiac thoracic sur-
gery has been limited somewhat because of the heteroge-
neous patient population and because, except for a few
centers, single institutions do not have large (eg, hundreds
of cases per year) patient populations to analyze. As a result,
most reports have focused on small numbers of patients
undergoing pulmonary resection. There seems to be good
evidence that the extent of pulmonary resection is associ-
ated with a differential incidence of postoperative AF, with
more arrhythmias after pneumonectomy than after lobec-
tomy. There have been reports of pharmacologic prophy-
laxis with digoxin, flecainide, verapamil, -blockers, ami-
odarone, and diltiazem, but these studies have included
small numbers of patients and produced mixed results. As a
result, in most thoracic surgery practices today, most pa-
tients probably receive no pharmacologic prophylaxis for
postoperative AF.
Vaporciyan and colleagues,1 elsewhere in this issue of
the Journal, report on a very detailed analysis of 2588
patients undergoing noncardiac thoracic surgical proce-
dures, focusing on the incidence and risk factors for post-
operative AF. These investigators report an overall inci-
dence of postoperative AF of 12.3%, and this is in keeping
with the results of previous reports. We learn from this
report that significant multivariate predictors of postopera-
tive AF include male sex, increasing patient age, history of
CHF, history of arrhythmias, and history of peripheral vas-
cular disease. We also learn that certain types of noncardiac
thoracic operations are associated with an increased risk of
postoperative AF, including resection of mediastinal tumor
or thymectomy, lobectomy, bilobectomy, and pneumonec-
tomy. In keeping with previous reports, more extensive
pulmonary resection (eg, pneumonectomy) was associated
with more postoperative AF than limited pulmonary resec-
tion (eg, lobectomy). Interestingly, the authors report that
intraoperative blood transfusion was a risk factor for post-
operative AF.
How should we use the information at hand about post-
operative AF after noncardiac thoracic surgery? Drawing on
our experience with patients undergoing cardiac surgery, it
is probably prudent to avoid -blocker withdrawal if pos-
sible and to use -blockers postoperatively in patients who
can tolerate these medications. We should also try to iden-
tify patients at high risk for postoperative AF who might be
appropriate candidates for prophylaxis. In this subset of
patients, it might be reasonable to consider the use of agents
such as amiodarone preoperatively and postoperatively to
try to prevent the development of postoperative AF.
Many important questions remain. The natural history of
postoperative AF after noncardiac surgery should be de-
fined. Are these arrhythmias, whether treated or not, self-
limiting? What is the rate of persistent or recurrent AF in
this patient population, and how does this affect the pa-
tient’s care? In the setting of cardiac surgery, it is widely
believed that antiarrhythmic medications can be discontin-
ued at 2 to 3 months after the operation, but is the same true
for patients undergoing noncardiac thoracic surgery? Large-
scale trials of pharmacologic prophylaxis and intraoperative
strategies are needed, and these will probably need to be
multi-institutional to accrue sufficient numbers of patients.
These are the sorts of trials that might be supported by our
professional organizations, such as the American College of
Surgeons, the American Association for Thoracic Surgery,
or the Society of Thoracic Surgeons. At this point, amioda-
rone administered orally for several days before the opera-
tion and then continued postoperatively is probably the most
attractive option. Unlike in cardiac surgery, many noncar-
diac thoracic surgery procedures are elective, allowing for a
week or more of pharmacologic therapy before the opera-
tion. It is obvious that we must have larger trials of potential
pharmacologic prophylaxis strategies, but we must also test
whether the administration of any prophylactic agent results
in not only fewer arrhythmias but also, for example, reduces
costs and decreases the length of hospital stay. The use of
intraoperative and perioperative strategies, such as thoracic
epidural anesthesia and atrial pacing, should also be tested
in these patients for efficacy. Lastly, a broader question
should be answered: Is anticoagulation with rate control as
effective as antiarrhythmic therapy for these patients?
The article by Vaporciyan and colleagues1 reminds us
that the issue of postoperative AF after noncardiac thoracic
surgery is an important one. We should learn more and do
more for our patients undergoing noncardiac thoracic sur-
gery to prevent this complication.
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